Medical Radioisotopes Industry Research Report 2023
Highlights
The global Medical Radioisotopes market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
North American market for Medical Radioisotopes is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.
Asia-Pacific market for Medical Radioisotopes is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.
The major global companies of Medical Radioisotopes include NRG, IRE, ANSTO, NTP Radioisotopes, China National Nuclear Corporation, Rosatom, Nordion, Eckert & Ziegler Strahlen and Polatom, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
The global market for Medical Radioisotopes in Nuclear Therapy is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.
Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, Tc-99m, which accounted for % of the global market of Medical Radioisotopes in 2022, is expected to reach million US$ by 2029, growing at a revised CAGR of % from 2024 to 2029.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Medical Radioisotopes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Radioisotopes.
The Medical Radioisotopes market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Medical Radioisotopes market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Medical Radioisotopes companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Global markets are presented by Medical Radioisotopes type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Medical Radioisotopes are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Medical Radioisotopes segment by Type
This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Medical Radioisotopes market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Medical Radioisotopes market.
Medical Radioisotopes Segment by Application
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Medical Radioisotopes market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Radioisotopes market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Medical Radioisotopes and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Medical Radioisotopes industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Radioisotopes.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Medical Radioisotopes companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
The global Medical Radioisotopes market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
North American market for Medical Radioisotopes is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.
Asia-Pacific market for Medical Radioisotopes is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.
The major global companies of Medical Radioisotopes include NRG, IRE, ANSTO, NTP Radioisotopes, China National Nuclear Corporation, Rosatom, Nordion, Eckert & Ziegler Strahlen and Polatom, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
The global market for Medical Radioisotopes in Nuclear Therapy is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.
Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, Tc-99m, which accounted for % of the global market of Medical Radioisotopes in 2022, is expected to reach million US$ by 2029, growing at a revised CAGR of % from 2024 to 2029.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Medical Radioisotopes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Radioisotopes.
The Medical Radioisotopes market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Medical Radioisotopes market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Medical Radioisotopes companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- NRG
- IRE
- ANSTO
- NTP Radioisotopes
- China National Nuclear Corporation
- Rosatom
- Nordion
- Eckert & Ziegler Strahlen
- Polatom
Global markets are presented by Medical Radioisotopes type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Medical Radioisotopes are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Medical Radioisotopes segment by Type
- Tc-99m
- Cobalt-60
- Iodine Radioisotopes
This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Medical Radioisotopes market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Medical Radioisotopes market.
Medical Radioisotopes Segment by Application
- Nuclear Therapy
- Equipment Radioactive Source
- Diagnosis
- Others
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Medical Radioisotopes market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Radioisotopes market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Medical Radioisotopes and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Medical Radioisotopes industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Radioisotopes.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Medical Radioisotopes companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Medical Radioisotopes by Type
2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029)
1.2.2 Tc-99m
1.2.3 Cobalt-60
1.2.4 Iodine Radioisotopes
2.3 Medical Radioisotopes by Application
2.3.1 Market Value Comparison by Application (2018 VS 2022 VS 2029)
2.3.2 Nuclear Therapy
2.3.3 Equipment Radioactive Source
2.3.4 Diagnosis
2.3.5 Others
2.4 Assumptions and Limitations
3 MEDICAL RADIOISOTOPES BREAKDOWN DATA BY TYPE
3.1 Global Medical Radioisotopes Historic Market Size by Type (2018-2023)
3.2 Global Medical Radioisotopes Forecasted Market Size by Type (2023-2028)
4 MEDICAL RADIOISOTOPES BREAKDOWN DATA BY APPLICATION
4.1 Global Medical Radioisotopes Historic Market Size by Application (2018-2023)
4.2 Global Medical Radioisotopes Forecasted Market Size by Application (2018-2023)
5 GLOBAL GROWTH TRENDS
5.1 Global Medical Radioisotopes Market Perspective (2018-2029)
5.2 Global Medical Radioisotopes Growth Trends by Region
5.2.1 Global Medical Radioisotopes Market Size by Region: 2018 VS 2022 VS 2029
5.2.2 Medical Radioisotopes Historic Market Size by Region (2018-2023)
5.2.3 Medical Radioisotopes Forecasted Market Size by Region (2024-2029)
5.3 Medical Radioisotopes Market Dynamics
5.3.1 Medical Radioisotopes Industry Trends
5.3.2 Medical Radioisotopes Market Drivers
5.3.3 Medical Radioisotopes Market Challenges
5.3.4 Medical Radioisotopes Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Medical Radioisotopes Players by Revenue
6.1.1 Global Top Medical Radioisotopes Players by Revenue (2018-2023)
6.1.2 Global Medical Radioisotopes Revenue Market Share by Players (2018-2023)
6.2 Global Medical Radioisotopes Industry Players Ranking, 2021 VS 2022 VS 2023
6.3 Global Key Players of Medical Radioisotopes Head office and Area Served
6.4 Global Medical Radioisotopes Players, Product Type & Application
6.5 Global Medical Radioisotopes Players, Date of Enter into This Industry
6.6 Global Medical Radioisotopes Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Medical Radioisotopes Market Size (2018-2029)
7.2 North America Medical Radioisotopes Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 North America Medical Radioisotopes Market Size by Country (2018-2023)
7.4 North America Medical Radioisotopes Market Size by Country (2024-2029)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Medical Radioisotopes Market Size (2018-2029)
8.2 Europe Medical Radioisotopes Market Growth Rate by Country: 2018 VS 2022 VS 2029
8.3 Europe Medical Radioisotopes Market Size by Country (2018-2023)
8.4 Europe Medical Radioisotopes Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Medical Radioisotopes Market Size (2018-2029)
9.2 Asia-Pacific Medical Radioisotopes Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Asia-Pacific Medical Radioisotopes Market Size by Country (2018-2023)
9.4 Asia-Pacific Medical Radioisotopes Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
10 LATIN AMERICA
10.1 Latin America Medical Radioisotopes Market Size (2018-2029)
10.2 Latin America Medical Radioisotopes Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Latin America Medical Radioisotopes Market Size by Country (2018-2023)
10.4 Latin America Medical Radioisotopes Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Medical Radioisotopes Market Size (2018-2029)
11.2 Middle East & Africa Medical Radioisotopes Market Growth Rate by Country: 2018 VS 2022 VS 2029
11.3 Middle East & Africa Medical Radioisotopes Market Size by Country (2018-2023)
11.4 Middle East & Africa Medical Radioisotopes Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
12 PLAYERS PROFILED
11.1 NRG
11.1.1 NRG Company Detail
11.1.2 NRG Business Overview
11.1.3 NRG Medical Radioisotopes Introduction
11.1.4 NRG Revenue in Medical Radioisotopes Business (2017-2022)
11.1.5 NRG Recent Development
11.2 IRE
11.2.1 IRE Company Detail
11.2.2 IRE Business Overview
11.2.3 IRE Medical Radioisotopes Introduction
11.2.4 IRE Revenue in Medical Radioisotopes Business (2017-2022)
11.2.5 IRE Recent Development
11.3 ANSTO
11.3.1 ANSTO Company Detail
11.3.2 ANSTO Business Overview
11.3.3 ANSTO Medical Radioisotopes Introduction
11.3.4 ANSTO Revenue in Medical Radioisotopes Business (2017-2022)
11.3.5 ANSTO Recent Development
11.4 NTP Radioisotopes
11.4.1 NTP Radioisotopes Company Detail
11.4.2 NTP Radioisotopes Business Overview
11.4.3 NTP Radioisotopes Medical Radioisotopes Introduction
11.4.4 NTP Radioisotopes Revenue in Medical Radioisotopes Business (2017-2022)
11.4.5 NTP Radioisotopes Recent Development
11.5 China National Nuclear Corporation
11.5.1 China National Nuclear Corporation Company Detail
11.5.2 China National Nuclear Corporation Business Overview
11.5.3 China National Nuclear Corporation Medical Radioisotopes Introduction
11.5.4 China National Nuclear Corporation Revenue in Medical Radioisotopes Business (2017-2022)
11.5.5 China National Nuclear Corporation Recent Development
11.6 Rosatom
11.6.1 Rosatom Company Detail
11.6.2 Rosatom Business Overview
11.6.3 Rosatom Medical Radioisotopes Introduction
11.6.4 Rosatom Revenue in Medical Radioisotopes Business (2017-2022)
11.6.5 Rosatom Recent Development
11.7 Nordion
11.7.1 Nordion Company Detail
11.7.2 Nordion Business Overview
11.7.3 Nordion Medical Radioisotopes Introduction
11.7.4 Nordion Revenue in Medical Radioisotopes Business (2017-2022)
11.7.5 Nordion Recent Development
11.8 Eckert & Ziegler Strahlen
11.8.1 Eckert & Ziegler Strahlen Company Detail
11.8.2 Eckert & Ziegler Strahlen Business Overview
11.8.3 Eckert & Ziegler Strahlen Medical Radioisotopes Introduction
11.8.4 Eckert & Ziegler Strahlen Revenue in Medical Radioisotopes Business (2017-2022)
11.8.5 Eckert & Ziegler Strahlen Recent Development
11.9 Polatom
11.9.1 Polatom Company Detail
11.9.2 Polatom Business Overview
11.9.3 Polatom Medical Radioisotopes Introduction
11.9.4 Polatom Revenue in Medical Radioisotopes Business (2017-2022)
11.9.5 Polatom Recent Development
13 REPORT CONCLUSION
14 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Medical Radioisotopes by Type
2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029)
1.2.2 Tc-99m
1.2.3 Cobalt-60
1.2.4 Iodine Radioisotopes
2.3 Medical Radioisotopes by Application
2.3.1 Market Value Comparison by Application (2018 VS 2022 VS 2029)
2.3.2 Nuclear Therapy
2.3.3 Equipment Radioactive Source
2.3.4 Diagnosis
2.3.5 Others
2.4 Assumptions and Limitations
3 MEDICAL RADIOISOTOPES BREAKDOWN DATA BY TYPE
3.1 Global Medical Radioisotopes Historic Market Size by Type (2018-2023)
3.2 Global Medical Radioisotopes Forecasted Market Size by Type (2023-2028)
4 MEDICAL RADIOISOTOPES BREAKDOWN DATA BY APPLICATION
4.1 Global Medical Radioisotopes Historic Market Size by Application (2018-2023)
4.2 Global Medical Radioisotopes Forecasted Market Size by Application (2018-2023)
5 GLOBAL GROWTH TRENDS
5.1 Global Medical Radioisotopes Market Perspective (2018-2029)
5.2 Global Medical Radioisotopes Growth Trends by Region
5.2.1 Global Medical Radioisotopes Market Size by Region: 2018 VS 2022 VS 2029
5.2.2 Medical Radioisotopes Historic Market Size by Region (2018-2023)
5.2.3 Medical Radioisotopes Forecasted Market Size by Region (2024-2029)
5.3 Medical Radioisotopes Market Dynamics
5.3.1 Medical Radioisotopes Industry Trends
5.3.2 Medical Radioisotopes Market Drivers
5.3.3 Medical Radioisotopes Market Challenges
5.3.4 Medical Radioisotopes Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Medical Radioisotopes Players by Revenue
6.1.1 Global Top Medical Radioisotopes Players by Revenue (2018-2023)
6.1.2 Global Medical Radioisotopes Revenue Market Share by Players (2018-2023)
6.2 Global Medical Radioisotopes Industry Players Ranking, 2021 VS 2022 VS 2023
6.3 Global Key Players of Medical Radioisotopes Head office and Area Served
6.4 Global Medical Radioisotopes Players, Product Type & Application
6.5 Global Medical Radioisotopes Players, Date of Enter into This Industry
6.6 Global Medical Radioisotopes Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Medical Radioisotopes Market Size (2018-2029)
7.2 North America Medical Radioisotopes Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 North America Medical Radioisotopes Market Size by Country (2018-2023)
7.4 North America Medical Radioisotopes Market Size by Country (2024-2029)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Medical Radioisotopes Market Size (2018-2029)
8.2 Europe Medical Radioisotopes Market Growth Rate by Country: 2018 VS 2022 VS 2029
8.3 Europe Medical Radioisotopes Market Size by Country (2018-2023)
8.4 Europe Medical Radioisotopes Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Medical Radioisotopes Market Size (2018-2029)
9.2 Asia-Pacific Medical Radioisotopes Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Asia-Pacific Medical Radioisotopes Market Size by Country (2018-2023)
9.4 Asia-Pacific Medical Radioisotopes Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
10 LATIN AMERICA
10.1 Latin America Medical Radioisotopes Market Size (2018-2029)
10.2 Latin America Medical Radioisotopes Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Latin America Medical Radioisotopes Market Size by Country (2018-2023)
10.4 Latin America Medical Radioisotopes Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Medical Radioisotopes Market Size (2018-2029)
11.2 Middle East & Africa Medical Radioisotopes Market Growth Rate by Country: 2018 VS 2022 VS 2029
11.3 Middle East & Africa Medical Radioisotopes Market Size by Country (2018-2023)
11.4 Middle East & Africa Medical Radioisotopes Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
12 PLAYERS PROFILED
11.1 NRG
11.1.1 NRG Company Detail
11.1.2 NRG Business Overview
11.1.3 NRG Medical Radioisotopes Introduction
11.1.4 NRG Revenue in Medical Radioisotopes Business (2017-2022)
11.1.5 NRG Recent Development
11.2 IRE
11.2.1 IRE Company Detail
11.2.2 IRE Business Overview
11.2.3 IRE Medical Radioisotopes Introduction
11.2.4 IRE Revenue in Medical Radioisotopes Business (2017-2022)
11.2.5 IRE Recent Development
11.3 ANSTO
11.3.1 ANSTO Company Detail
11.3.2 ANSTO Business Overview
11.3.3 ANSTO Medical Radioisotopes Introduction
11.3.4 ANSTO Revenue in Medical Radioisotopes Business (2017-2022)
11.3.5 ANSTO Recent Development
11.4 NTP Radioisotopes
11.4.1 NTP Radioisotopes Company Detail
11.4.2 NTP Radioisotopes Business Overview
11.4.3 NTP Radioisotopes Medical Radioisotopes Introduction
11.4.4 NTP Radioisotopes Revenue in Medical Radioisotopes Business (2017-2022)
11.4.5 NTP Radioisotopes Recent Development
11.5 China National Nuclear Corporation
11.5.1 China National Nuclear Corporation Company Detail
11.5.2 China National Nuclear Corporation Business Overview
11.5.3 China National Nuclear Corporation Medical Radioisotopes Introduction
11.5.4 China National Nuclear Corporation Revenue in Medical Radioisotopes Business (2017-2022)
11.5.5 China National Nuclear Corporation Recent Development
11.6 Rosatom
11.6.1 Rosatom Company Detail
11.6.2 Rosatom Business Overview
11.6.3 Rosatom Medical Radioisotopes Introduction
11.6.4 Rosatom Revenue in Medical Radioisotopes Business (2017-2022)
11.6.5 Rosatom Recent Development
11.7 Nordion
11.7.1 Nordion Company Detail
11.7.2 Nordion Business Overview
11.7.3 Nordion Medical Radioisotopes Introduction
11.7.4 Nordion Revenue in Medical Radioisotopes Business (2017-2022)
11.7.5 Nordion Recent Development
11.8 Eckert & Ziegler Strahlen
11.8.1 Eckert & Ziegler Strahlen Company Detail
11.8.2 Eckert & Ziegler Strahlen Business Overview
11.8.3 Eckert & Ziegler Strahlen Medical Radioisotopes Introduction
11.8.4 Eckert & Ziegler Strahlen Revenue in Medical Radioisotopes Business (2017-2022)
11.8.5 Eckert & Ziegler Strahlen Recent Development
11.9 Polatom
11.9.1 Polatom Company Detail
11.9.2 Polatom Business Overview
11.9.3 Polatom Medical Radioisotopes Introduction
11.9.4 Polatom Revenue in Medical Radioisotopes Business (2017-2022)
11.9.5 Polatom Recent Development
13 REPORT CONCLUSION
14 DISCLAIMER
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Medical Radioisotopes Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Medical Radioisotopes Revenue Market Share by Type (2018-2023)
Table 7. Global Medical Radioisotopes Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Medical Radioisotopes Revenue Market Share by Type (2024-2029)
Table 9. Global Medical Radioisotopes Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Medical Radioisotopes Revenue Market Share by Application (2018-2023)
Table 11. Global Medical Radioisotopes Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Medical Radioisotopes Revenue Market Share by Application (2024-2029)
Table 13. Global Medical Radioisotopes Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Medical Radioisotopes Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Medical Radioisotopes Market Share by Region (2018-2023)
Table 16. Global Medical Radioisotopes Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Medical Radioisotopes Market Share by Region (2024-2029)
Table 18. Medical Radioisotopes Market Trends
Table 19. Medical Radioisotopes Market Drivers
Table 20. Medical Radioisotopes Market Challenges
Table 21. Medical Radioisotopes Market Restraints
Table 22. Global Top Medical Radioisotopes Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Medical Radioisotopes Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Medical Radioisotopes Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Medical Radioisotopes, Headquarters and Area Served
Table 26. Global Medical Radioisotopes Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Medical Radioisotopes by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Medical Radioisotopes Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Medical Radioisotopes Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Medical Radioisotopes Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Medical Radioisotopes Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Medical Radioisotopes Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Medical Radioisotopes Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Medical Radioisotopes Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Medical Radioisotopes Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Medical Radioisotopes Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Medical Radioisotopes Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Medical Radioisotopes Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Medical Radioisotopes Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Medical Radioisotopes Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Medical Radioisotopes Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Medical Radioisotopes Market Size by Country (2024-2029) & (US$ Million)
Table 45. NRG Company Detail
Table 46. NRG Business Overview
Table 47. NRG Medical Radioisotopes Product
Table 48. NRG Revenue in Medical Radioisotopes Business (2017-2022) & (US$ Million)
Table 49. NRG Recent Development
Table 50. IRE Company Detail
Table 51. IRE Business Overview
Table 52. IRE Medical Radioisotopes Product
Table 53. IRE Revenue in Medical Radioisotopes Business (2017-2022) & (US$ Million)
Table 54. IRE Recent Development
Table 55. ANSTO Company Detail
Table 56. ANSTO Business Overview
Table 57. ANSTO Medical Radioisotopes Product
Table 58. ANSTO Revenue in Medical Radioisotopes Business (2017-2022) & (US$ Million)
Table 59. ANSTO Recent Development
Table 60. NTP Radioisotopes Company Detail
Table 61. NTP Radioisotopes Business Overview
Table 62. NTP Radioisotopes Medical Radioisotopes Product
Table 63. NTP Radioisotopes Revenue in Medical Radioisotopes Business (2017-2022) & (US$ Million)
Table 64. NTP Radioisotopes Recent Development
Table 65. China National Nuclear Corporation Company Detail
Table 66. China National Nuclear Corporation Business Overview
Table 67. China National Nuclear Corporation Medical Radioisotopes Product
Table 68. China National Nuclear Corporation Revenue in Medical Radioisotopes Business (2017-2022) & (US$ Million)
Table 69. China National Nuclear Corporation Recent Development
Table 70. Rosatom Company Detail
Table 71. Rosatom Business Overview
Table 72. Rosatom Medical Radioisotopes Product
Table 73. Rosatom Revenue in Medical Radioisotopes Business (2017-2022) & (US$ Million)
Table 74. Rosatom Recent Development
Table 75. Nordion Company Detail
Table 76. Nordion Business Overview
Table 77. Nordion Medical Radioisotopes Product
Table 78. Nordion Revenue in Medical Radioisotopes Business (2017-2022) & (US$ Million)
Table 79. Nordion Recent Development
Table 80. Eckert & Ziegler Strahlen Company Detail
Table 81. Eckert & Ziegler Strahlen Business Overview
Table 82. Eckert & Ziegler Strahlen Medical Radioisotopes Product
Table 83. Eckert & Ziegler Strahlen Revenue in Medical Radioisotopes Business (2017-2022) & (US$ Million)
Table 84. Eckert & Ziegler Strahlen Recent Development
Table 85. Polatom Company Detail
Table 86. Polatom Business Overview
Table 87. Polatom Medical Radioisotopes Product
Table 88. Polatom Revenue in Medical Radioisotopes Business (2017-2022) & (US$ Million)
Table 89. Polatom Recent Development
Table 90. NRG Company Information
Table 91. NRG Business Overview
Table 92. NRG Medical Radioisotopes Revenue in Medical Radioisotopes Business (2018-2023) & (US$ Million)
Table 93. NRG Revenue in Medical Radioisotopes Business (2018-2023) & (US$ Million) Portfolio
Table 94. NRG Recent Development
Table 95. IRE Company Information
Table 96. IRE Business Overview
Table 97. IRE Medical Radioisotopes Revenue in Medical Radioisotopes Business (2018-2023) & (US$ Million)
Table 98. IRE Revenue in Medical Radioisotopes Business (2018-2023) & (US$ Million) Portfolio
Table 99. IRE Recent Development
Table 100. ANSTO Company Information
Table 101. ANSTO Business Overview
Table 102. ANSTO Medical Radioisotopes Revenue in Medical Radioisotopes Business (2018-2023) & (US$ Million)
Table 103. ANSTO Revenue in Medical Radioisotopes Business (2018-2023) & (US$ Million) Portfolio
Table 104. ANSTO Recent Development
Table 105. NTP Radioisotopes Company Information
Table 106. NTP Radioisotopes Business Overview
Table 107. NTP Radioisotopes Medical Radioisotopes Revenue in Medical Radioisotopes Business (2018-2023) & (US$ Million)
Table 108. NTP Radioisotopes Revenue in Medical Radioisotopes Business (2018-2023) & (US$ Million) Portfolio
Table 109. NTP Radioisotopes Recent Development
Table 110. China National Nuclear Corporation Company Information
Table 111. China National Nuclear Corporation Business Overview
Table 112. China National Nuclear Corporation Medical Radioisotopes Revenue in Medical Radioisotopes Business (2018-2023) & (US$ Million)
Table 113. China National Nuclear Corporation Revenue in Medical Radioisotopes Business (2018-2023) & (US$ Million) Portfolio
Table 114. China National Nuclear Corporation Recent Development
Table 115. Rosatom Company Information
Table 116. Rosatom Business Overview
Table 117. Rosatom Medical Radioisotopes Revenue in Medical Radioisotopes Business (2018-2023) & (US$ Million)
Table 118. Rosatom Revenue in Medical Radioisotopes Business (2018-2023) & (US$ Million) Portfolio
Table 119. Rosatom Recent Development
Table 120. Nordion Company Information
Table 121. Nordion Business Overview
Table 122. Nordion Medical Radioisotopes Revenue in Medical Radioisotopes Business (2018-2023) & (US$ Million)
Table 123. Nordion Revenue in Medical Radioisotopes Business (2018-2023) & (US$ Million) Portfolio
Table 124. Nordion Recent Development
Table 125. Eckert & Ziegler Strahlen Company Information
Table 126. Eckert & Ziegler Strahlen Business Overview
Table 127. Eckert & Ziegler Strahlen Medical Radioisotopes Revenue in Medical Radioisotopes Business (2018-2023) & (US$ Million)
Table 128. Eckert & Ziegler Strahlen Revenue in Medical Radioisotopes Business (2018-2023) & (US$ Million) Portfolio
Table 129. Eckert & Ziegler Strahlen Recent Development
Table 130. Polatom Company Information
Table 131. Polatom Business Overview
Table 132. Polatom Medical Radioisotopes Revenue in Medical Radioisotopes Business (2018-2023) & (US$ Million)
Table 133. Polatom Revenue in Medical Radioisotopes Business (2018-2023) & (US$ Million) Portfolio
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Medical Radioisotopes Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Medical Radioisotopes Revenue Market Share by Type (2018-2023)
Table 7. Global Medical Radioisotopes Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Medical Radioisotopes Revenue Market Share by Type (2024-2029)
Table 9. Global Medical Radioisotopes Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Medical Radioisotopes Revenue Market Share by Application (2018-2023)
Table 11. Global Medical Radioisotopes Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Medical Radioisotopes Revenue Market Share by Application (2024-2029)
Table 13. Global Medical Radioisotopes Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Medical Radioisotopes Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Medical Radioisotopes Market Share by Region (2018-2023)
Table 16. Global Medical Radioisotopes Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Medical Radioisotopes Market Share by Region (2024-2029)
Table 18. Medical Radioisotopes Market Trends
Table 19. Medical Radioisotopes Market Drivers
Table 20. Medical Radioisotopes Market Challenges
Table 21. Medical Radioisotopes Market Restraints
Table 22. Global Top Medical Radioisotopes Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Medical Radioisotopes Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Medical Radioisotopes Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Medical Radioisotopes, Headquarters and Area Served
Table 26. Global Medical Radioisotopes Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Medical Radioisotopes by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Medical Radioisotopes Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Medical Radioisotopes Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Medical Radioisotopes Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Medical Radioisotopes Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Medical Radioisotopes Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Medical Radioisotopes Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Medical Radioisotopes Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Medical Radioisotopes Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Medical Radioisotopes Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Medical Radioisotopes Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Medical Radioisotopes Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Medical Radioisotopes Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Medical Radioisotopes Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Medical Radioisotopes Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Medical Radioisotopes Market Size by Country (2024-2029) & (US$ Million)
Table 45. NRG Company Detail
Table 46. NRG Business Overview
Table 47. NRG Medical Radioisotopes Product
Table 48. NRG Revenue in Medical Radioisotopes Business (2017-2022) & (US$ Million)
Table 49. NRG Recent Development
Table 50. IRE Company Detail
Table 51. IRE Business Overview
Table 52. IRE Medical Radioisotopes Product
Table 53. IRE Revenue in Medical Radioisotopes Business (2017-2022) & (US$ Million)
Table 54. IRE Recent Development
Table 55. ANSTO Company Detail
Table 56. ANSTO Business Overview
Table 57. ANSTO Medical Radioisotopes Product
Table 58. ANSTO Revenue in Medical Radioisotopes Business (2017-2022) & (US$ Million)
Table 59. ANSTO Recent Development
Table 60. NTP Radioisotopes Company Detail
Table 61. NTP Radioisotopes Business Overview
Table 62. NTP Radioisotopes Medical Radioisotopes Product
Table 63. NTP Radioisotopes Revenue in Medical Radioisotopes Business (2017-2022) & (US$ Million)
Table 64. NTP Radioisotopes Recent Development
Table 65. China National Nuclear Corporation Company Detail
Table 66. China National Nuclear Corporation Business Overview
Table 67. China National Nuclear Corporation Medical Radioisotopes Product
Table 68. China National Nuclear Corporation Revenue in Medical Radioisotopes Business (2017-2022) & (US$ Million)
Table 69. China National Nuclear Corporation Recent Development
Table 70. Rosatom Company Detail
Table 71. Rosatom Business Overview
Table 72. Rosatom Medical Radioisotopes Product
Table 73. Rosatom Revenue in Medical Radioisotopes Business (2017-2022) & (US$ Million)
Table 74. Rosatom Recent Development
Table 75. Nordion Company Detail
Table 76. Nordion Business Overview
Table 77. Nordion Medical Radioisotopes Product
Table 78. Nordion Revenue in Medical Radioisotopes Business (2017-2022) & (US$ Million)
Table 79. Nordion Recent Development
Table 80. Eckert & Ziegler Strahlen Company Detail
Table 81. Eckert & Ziegler Strahlen Business Overview
Table 82. Eckert & Ziegler Strahlen Medical Radioisotopes Product
Table 83. Eckert & Ziegler Strahlen Revenue in Medical Radioisotopes Business (2017-2022) & (US$ Million)
Table 84. Eckert & Ziegler Strahlen Recent Development
Table 85. Polatom Company Detail
Table 86. Polatom Business Overview
Table 87. Polatom Medical Radioisotopes Product
Table 88. Polatom Revenue in Medical Radioisotopes Business (2017-2022) & (US$ Million)
Table 89. Polatom Recent Development
Table 90. NRG Company Information
Table 91. NRG Business Overview
Table 92. NRG Medical Radioisotopes Revenue in Medical Radioisotopes Business (2018-2023) & (US$ Million)
Table 93. NRG Revenue in Medical Radioisotopes Business (2018-2023) & (US$ Million) Portfolio
Table 94. NRG Recent Development
Table 95. IRE Company Information
Table 96. IRE Business Overview
Table 97. IRE Medical Radioisotopes Revenue in Medical Radioisotopes Business (2018-2023) & (US$ Million)
Table 98. IRE Revenue in Medical Radioisotopes Business (2018-2023) & (US$ Million) Portfolio
Table 99. IRE Recent Development
Table 100. ANSTO Company Information
Table 101. ANSTO Business Overview
Table 102. ANSTO Medical Radioisotopes Revenue in Medical Radioisotopes Business (2018-2023) & (US$ Million)
Table 103. ANSTO Revenue in Medical Radioisotopes Business (2018-2023) & (US$ Million) Portfolio
Table 104. ANSTO Recent Development
Table 105. NTP Radioisotopes Company Information
Table 106. NTP Radioisotopes Business Overview
Table 107. NTP Radioisotopes Medical Radioisotopes Revenue in Medical Radioisotopes Business (2018-2023) & (US$ Million)
Table 108. NTP Radioisotopes Revenue in Medical Radioisotopes Business (2018-2023) & (US$ Million) Portfolio
Table 109. NTP Radioisotopes Recent Development
Table 110. China National Nuclear Corporation Company Information
Table 111. China National Nuclear Corporation Business Overview
Table 112. China National Nuclear Corporation Medical Radioisotopes Revenue in Medical Radioisotopes Business (2018-2023) & (US$ Million)
Table 113. China National Nuclear Corporation Revenue in Medical Radioisotopes Business (2018-2023) & (US$ Million) Portfolio
Table 114. China National Nuclear Corporation Recent Development
Table 115. Rosatom Company Information
Table 116. Rosatom Business Overview
Table 117. Rosatom Medical Radioisotopes Revenue in Medical Radioisotopes Business (2018-2023) & (US$ Million)
Table 118. Rosatom Revenue in Medical Radioisotopes Business (2018-2023) & (US$ Million) Portfolio
Table 119. Rosatom Recent Development
Table 120. Nordion Company Information
Table 121. Nordion Business Overview
Table 122. Nordion Medical Radioisotopes Revenue in Medical Radioisotopes Business (2018-2023) & (US$ Million)
Table 123. Nordion Revenue in Medical Radioisotopes Business (2018-2023) & (US$ Million) Portfolio
Table 124. Nordion Recent Development
Table 125. Eckert & Ziegler Strahlen Company Information
Table 126. Eckert & Ziegler Strahlen Business Overview
Table 127. Eckert & Ziegler Strahlen Medical Radioisotopes Revenue in Medical Radioisotopes Business (2018-2023) & (US$ Million)
Table 128. Eckert & Ziegler Strahlen Revenue in Medical Radioisotopes Business (2018-2023) & (US$ Million) Portfolio
Table 129. Eckert & Ziegler Strahlen Recent Development
Table 130. Polatom Company Information
Table 131. Polatom Business Overview
Table 132. Polatom Medical Radioisotopes Revenue in Medical Radioisotopes Business (2018-2023) & (US$ Million)
Table 133. Polatom Revenue in Medical Radioisotopes Business (2018-2023) & (US$ Million) Portfolio
